Physician Wealth Advisors’s Rentokil RTO Stock Holding History

Physician Wealth Advisors’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$372	Sell	13 -28	-68%	-$889	﹤0.01%	2265
2026 Q1	$1.29K	Hold	41	–	–	﹤0.01%	1543
2025 Q4	$1.21K	Buy	41 +13	+46%	+$361	﹤0.01%	1516
2025 Q3	$707	Hold	28	–	–	﹤0.01%	1729
2025 Q2	$672	Buy	+28	New	+$649	﹤0.01%	1625
2025 Q1	–	Sell	-24	Closed	-$608	–	1517
2024 Q4	$608	Buy	+24	New	+$608	﹤0.01%	1087

Other funds holding RTO

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Physician Wealth Advisors's RTO Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Rentokil (RTO) stake by 68% in Q2 2026, selling an estimated $889 and leaving 13 shares worth $372. The position accounts for ﹤0.01% of the portfolio, ranked #2265.

Physician Wealth Advisors first reported a position in RTO in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.29K in Q1 2026. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

Physician Wealth Advisors held 13 shares of Rentokil worth $372 as of Q2 2026.
Physician Wealth Advisors sold 28 Rentokil shares in Q2 2026, an estimated $889.
Rentokil made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2265 holding.
Physician Wealth Advisors first reported a position in Rentokil in Q4 2024 and has held it in 6 quarters since.
Physician Wealth Advisors's Rentokil position peaked at $1.29K in Q1 2026.
285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.